These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. Chen HS, Lipton SA. J Pharmacol Exp Ther; 2005 Sep 01; 314(3):961-71. PubMed ID: 15901795 [Abstract] [Full Text] [Related]
14. Differences in degree of trapping of low-affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block. Mealing GA, Lanthorn TH, Murray CL, Small DL, Morley P. J Pharmacol Exp Ther; 1999 Jan 01; 288(1):204-10. PubMed ID: 9862772 [Abstract] [Full Text] [Related]
15. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor. Masuko T, Nagaoka H, Miyake M, Metori K, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T. Neurochem Int; 2007 Jan 01; 50(2):443-9. PubMed ID: 17113196 [Abstract] [Full Text] [Related]
18. Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors. Plazas PV, Savino J, Kracun S, Gomez-Casati ME, Katz E, Parsons CG, Millar NS, Elgoyhen AB. Eur J Pharmacol; 2007 Jul 02; 566(1-3):11-9. PubMed ID: 17466293 [Abstract] [Full Text] [Related]
19. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M. Eur J Neurosci; 2006 May 02; 23(10):2611-22. PubMed ID: 16817864 [Abstract] [Full Text] [Related]
20. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors. Kloda A, Clements JD, Lewis RJ, Adams DJ. Mol Pharmacol; 2004 Jun 02; 65(6):1386-96. PubMed ID: 15155832 [Abstract] [Full Text] [Related] Page: [Next] [New Search]